| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $311K | -98.5% |
| Cost of Revenue | $364K | -72.0% |
| R&D Expense | $748K | -6.3% |
| SG&A Expense | $12.0M | +6.7% |
| Operating Income | -$16.3M | -192.1% |
| Pre-tax Income | -$24.2M | +54.9% |
| Income Tax | $590K | +3833.3% |
| Net Income | $21.1M | +130.3% |
| EPS (Basic) | $5.97 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $161K | -96.5% |
| Accounts Receivable | $3K | -99.5% |
| Current Assets | $639K | -99.4% |
| Total Assets | $7.7M | -95.8% |
| Current Liabilities | $39.6M | -84.0% |
| Long-term Debt | $28.7M | -85.5% |
| Total Liabilities | $41.6M | -83.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $1.5M | -68.7% |
| +741.9% |
| EPS (Diluted) | $5.97 | +741.9% |
| Stockholders' Equity |
| -$33.9M |
| +46.4% |